T cells with low CD2 levels express reduced restriction factors and are preferentially infected in therapy naïve chronic HIV‐1 patients
Introduction: Restriction factors (RFs) suppress HIV‐1 in cell lines and primary cell models. Hence, RFs might be attractive targets for novel antiviral strategies, but their importance for virus control in vivo is controversial. Methods: We profiled the expression of RFs in primary blood‐derived mo...
Gespeichert in:
Veröffentlicht in: | Journal of the International AIDS Society 2017, Vol.20 (1), p.21865-n/a |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | n/a |
---|---|
container_issue | 1 |
container_start_page | 21865 |
container_title | Journal of the International AIDS Society |
container_volume | 20 |
creator | Bolduan, Sebastian Koppensteiner, Herwig Businger, Ramona Rebensburg, Stephanie Kunze, Christine Brack‐Werner, Ruth Draenert, Rika Schindler, Michael |
description | Introduction: Restriction factors (RFs) suppress HIV‐1 in cell lines and primary cell models. Hence, RFs might be attractive targets for novel antiviral strategies, but their importance for virus control in vivo is controversial.
Methods: We profiled the expression of RFs in primary blood‐derived mononuclear cells (PBMC) from therapy‐naïve HIV‐1 patients and quantified infection.
Results: Overall, there was no correlation between individual RF expression and HIV‐1 status in total PBMC. However, we identified a T cell population with low levels of intracellular CD2 and reduced expression of SAMHD1, p21 and SerinC5. CD2low T cells with reduced RF expression were markedly positive for HIV‐1 p24. In contrast, CD2+ T cells were less infected and expressed higher levels of RFs. CD2low T cell infection correlated with viral loads and was associated with HIV‐1 disease progression.
Conclusions: In untreated therapy naïve chronic HIV‐1 patients, RF expression in T cells is associated with CD2 expression and seems to influence viral loads. Our study suggests that RFs help to control HIV‐1 infection in certain T cells in vivo and supports the potential for RFs as promising targets for therapeutic intervention. |
doi_str_mv | 10.7448/IAS.20.1.21865 |
format | Article |
fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5964667</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A518588519</galeid><sourcerecordid>A518588519</sourcerecordid><originalsourceid>FETCH-LOGICAL-c7635-d4cfe12fa201ef03a4a4147169fd77a158fb0a2d4781b88468ba4492420bf8323</originalsourceid><addsrcrecordid>eNqNk8-O0zAQxiMEYpeFK0dkCWnFpcF2HNu5IFXlzxatxIGFq-U6TuOVaxc7aemNMyfehIfgTXgS3O1StVCWVaQ4sn_zfePJTJY9RjBnhPDn4-H7HMMc5RhxWt7JjhEr-QDTEt_d-T7KHsR4CSHFnFT3syPMq7IoMDvOvl4Apa2NYGm6Fli_BKOXGFi90GlPf54HHSMIuu6VrtMau2BUZ7wDjVSdDxFIVwMZNEhko4N2nZHWroBxjVZdijEOdK0Ocr4CTv74vtBAtcE7o8DZ-OPPL98QmMvOpLj4MLvXSBv1o-v1JPvw-tXF6Gxw_u7NeDQ8HyhGi3JQE9VohBuJIdINLCSRBBGGaNXUjElU8mYCJa4J42jCOaF8IgmpMMFw0vACFyfZi43uvJ_MdK2Sd5BWzIOZybASXhqxf-JMK6Z-IcqKEkpZEnh2LRD8pz7VRMxMXFdROu37KFBFikTykif06R_ope-DS9cTBaSMIlJdZfRPCuMKFpCz9N5SU2m1SAX2KTu1thbDEiU3XqLqZgpWiGIG146DA9RUu_SnrHe6MWl7T_VW_I5-foBPT61nRh00uF3AjsPpTkCrpe3a6G2_bs64r3wz-HfOKvgYUztvWwJBsR42kYZNYCiQuBq2FPBkt5G2-O_pSgDZAMuU_Oo_cuLteLjR_QVMizEP</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2290308790</pqid></control><display><type>article</type><title>T cells with low CD2 levels express reduced restriction factors and are preferentially infected in therapy naïve chronic HIV‐1 patients</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Access via Wiley Online Library</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Wiley Online Library (Open Access Collection)</source><source>PubMed Central</source><creator>Bolduan, Sebastian ; Koppensteiner, Herwig ; Businger, Ramona ; Rebensburg, Stephanie ; Kunze, Christine ; Brack‐Werner, Ruth ; Draenert, Rika ; Schindler, Michael</creator><creatorcontrib>Bolduan, Sebastian ; Koppensteiner, Herwig ; Businger, Ramona ; Rebensburg, Stephanie ; Kunze, Christine ; Brack‐Werner, Ruth ; Draenert, Rika ; Schindler, Michael</creatorcontrib><description>Introduction: Restriction factors (RFs) suppress HIV‐1 in cell lines and primary cell models. Hence, RFs might be attractive targets for novel antiviral strategies, but their importance for virus control in vivo is controversial.
Methods: We profiled the expression of RFs in primary blood‐derived mononuclear cells (PBMC) from therapy‐naïve HIV‐1 patients and quantified infection.
Results: Overall, there was no correlation between individual RF expression and HIV‐1 status in total PBMC. However, we identified a T cell population with low levels of intracellular CD2 and reduced expression of SAMHD1, p21 and SerinC5. CD2low T cells with reduced RF expression were markedly positive for HIV‐1 p24. In contrast, CD2+ T cells were less infected and expressed higher levels of RFs. CD2low T cell infection correlated with viral loads and was associated with HIV‐1 disease progression.
Conclusions: In untreated therapy naïve chronic HIV‐1 patients, RF expression in T cells is associated with CD2 expression and seems to influence viral loads. Our study suggests that RFs help to control HIV‐1 infection in certain T cells in vivo and supports the potential for RFs as promising targets for therapeutic intervention.</description><identifier>ISSN: 1758-2652</identifier><identifier>EISSN: 1758-2652</identifier><identifier>DOI: 10.7448/IAS.20.1.21865</identifier><identifier>PMID: 28953327</identifier><language>eng</language><publisher>Switzerland: International AIDS Society</publisher><subject>Acquired immune deficiency syndrome ; Adult ; Aged ; AIDS ; AIDS/HIV ; Antiviral agents ; Cells ; Cloning ; Control ; Dosage and administration ; Drug therapy ; Experiments ; Female ; Health aspects ; Hepatitis ; HIV ; HIV infections ; HIV Infections - genetics ; HIV Infections - immunology ; HIV Infections - virology ; HIV patients ; HIV-1 - physiology ; HIV‐1 ; Human immunodeficiency virus ; Humans ; Immune system ; in vivo relevance ; Infections ; Interferon ; Leukocytes, Mononuclear - immunology ; Leukocytes, Mononuclear - virology ; Lymphocytes ; Male ; Middle Aged ; p21 ; Patients ; Physiological aspects ; Proteins ; restriction factors ; RISP ; SAM Domain and HD Domain-Containing Protein 1 - genetics ; SAM Domain and HD Domain-Containing Protein 1 - immunology ; SAMHD1 ; SerinC5 ; T cells ; T-Lymphocytes - immunology ; T-Lymphocytes - virology ; Tetherin ; Viral Load ; Viruses</subject><ispartof>Journal of the International AIDS Society, 2017, Vol.20 (1), p.21865-n/a</ispartof><rights>2017 Bolduan S et al; licensee International AIDS Society</rights><rights>COPYRIGHT 2017 International AIDS Society</rights><rights>2017. This work is published under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Bolduan S et al; licensee International AIDS Society. The Author(s)</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c7635-d4cfe12fa201ef03a4a4147169fd77a158fb0a2d4781b88468ba4492420bf8323</citedby><cites>FETCH-LOGICAL-c7635-d4cfe12fa201ef03a4a4147169fd77a158fb0a2d4781b88468ba4492420bf8323</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5964667/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5964667/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,1417,4024,11562,27923,27924,27925,45574,45575,46052,46476,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28953327$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bolduan, Sebastian</creatorcontrib><creatorcontrib>Koppensteiner, Herwig</creatorcontrib><creatorcontrib>Businger, Ramona</creatorcontrib><creatorcontrib>Rebensburg, Stephanie</creatorcontrib><creatorcontrib>Kunze, Christine</creatorcontrib><creatorcontrib>Brack‐Werner, Ruth</creatorcontrib><creatorcontrib>Draenert, Rika</creatorcontrib><creatorcontrib>Schindler, Michael</creatorcontrib><title>T cells with low CD2 levels express reduced restriction factors and are preferentially infected in therapy naïve chronic HIV‐1 patients</title><title>Journal of the International AIDS Society</title><addtitle>J Int AIDS Soc</addtitle><description>Introduction: Restriction factors (RFs) suppress HIV‐1 in cell lines and primary cell models. Hence, RFs might be attractive targets for novel antiviral strategies, but their importance for virus control in vivo is controversial.
Methods: We profiled the expression of RFs in primary blood‐derived mononuclear cells (PBMC) from therapy‐naïve HIV‐1 patients and quantified infection.
Results: Overall, there was no correlation between individual RF expression and HIV‐1 status in total PBMC. However, we identified a T cell population with low levels of intracellular CD2 and reduced expression of SAMHD1, p21 and SerinC5. CD2low T cells with reduced RF expression were markedly positive for HIV‐1 p24. In contrast, CD2+ T cells were less infected and expressed higher levels of RFs. CD2low T cell infection correlated with viral loads and was associated with HIV‐1 disease progression.
Conclusions: In untreated therapy naïve chronic HIV‐1 patients, RF expression in T cells is associated with CD2 expression and seems to influence viral loads. Our study suggests that RFs help to control HIV‐1 infection in certain T cells in vivo and supports the potential for RFs as promising targets for therapeutic intervention.</description><subject>Acquired immune deficiency syndrome</subject><subject>Adult</subject><subject>Aged</subject><subject>AIDS</subject><subject>AIDS/HIV</subject><subject>Antiviral agents</subject><subject>Cells</subject><subject>Cloning</subject><subject>Control</subject><subject>Dosage and administration</subject><subject>Drug therapy</subject><subject>Experiments</subject><subject>Female</subject><subject>Health aspects</subject><subject>Hepatitis</subject><subject>HIV</subject><subject>HIV infections</subject><subject>HIV Infections - genetics</subject><subject>HIV Infections - immunology</subject><subject>HIV Infections - virology</subject><subject>HIV patients</subject><subject>HIV-1 - physiology</subject><subject>HIV‐1</subject><subject>Human immunodeficiency virus</subject><subject>Humans</subject><subject>Immune system</subject><subject>in vivo relevance</subject><subject>Infections</subject><subject>Interferon</subject><subject>Leukocytes, Mononuclear - immunology</subject><subject>Leukocytes, Mononuclear - virology</subject><subject>Lymphocytes</subject><subject>Male</subject><subject>Middle Aged</subject><subject>p21</subject><subject>Patients</subject><subject>Physiological aspects</subject><subject>Proteins</subject><subject>restriction factors</subject><subject>RISP</subject><subject>SAM Domain and HD Domain-Containing Protein 1 - genetics</subject><subject>SAM Domain and HD Domain-Containing Protein 1 - immunology</subject><subject>SAMHD1</subject><subject>SerinC5</subject><subject>T cells</subject><subject>T-Lymphocytes - immunology</subject><subject>T-Lymphocytes - virology</subject><subject>Tetherin</subject><subject>Viral Load</subject><subject>Viruses</subject><issn>1758-2652</issn><issn>1758-2652</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>WIN</sourceid><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNqNk8-O0zAQxiMEYpeFK0dkCWnFpcF2HNu5IFXlzxatxIGFq-U6TuOVaxc7aemNMyfehIfgTXgS3O1StVCWVaQ4sn_zfePJTJY9RjBnhPDn4-H7HMMc5RhxWt7JjhEr-QDTEt_d-T7KHsR4CSHFnFT3syPMq7IoMDvOvl4Apa2NYGm6Fli_BKOXGFi90GlPf54HHSMIuu6VrtMau2BUZ7wDjVSdDxFIVwMZNEhko4N2nZHWroBxjVZdijEOdK0Ocr4CTv74vtBAtcE7o8DZ-OPPL98QmMvOpLj4MLvXSBv1o-v1JPvw-tXF6Gxw_u7NeDQ8HyhGi3JQE9VohBuJIdINLCSRBBGGaNXUjElU8mYCJa4J42jCOaF8IgmpMMFw0vACFyfZi43uvJ_MdK2Sd5BWzIOZybASXhqxf-JMK6Z-IcqKEkpZEnh2LRD8pz7VRMxMXFdROu37KFBFikTykif06R_ope-DS9cTBaSMIlJdZfRPCuMKFpCz9N5SU2m1SAX2KTu1thbDEiU3XqLqZgpWiGIG146DA9RUu_SnrHe6MWl7T_VW_I5-foBPT61nRh00uF3AjsPpTkCrpe3a6G2_bs64r3wz-HfOKvgYUztvWwJBsR42kYZNYCiQuBq2FPBkt5G2-O_pSgDZAMuU_Oo_cuLteLjR_QVMizEP</recordid><startdate>2017</startdate><enddate>2017</enddate><creator>Bolduan, Sebastian</creator><creator>Koppensteiner, Herwig</creator><creator>Businger, Ramona</creator><creator>Rebensburg, Stephanie</creator><creator>Kunze, Christine</creator><creator>Brack‐Werner, Ruth</creator><creator>Draenert, Rika</creator><creator>Schindler, Michael</creator><general>International AIDS Society</general><general>John Wiley & Sons, Inc</general><general>Taylor & Francis</general><scope>24P</scope><scope>WIN</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>2017</creationdate><title>T cells with low CD2 levels express reduced restriction factors and are preferentially infected in therapy naïve chronic HIV‐1 patients</title><author>Bolduan, Sebastian ; Koppensteiner, Herwig ; Businger, Ramona ; Rebensburg, Stephanie ; Kunze, Christine ; Brack‐Werner, Ruth ; Draenert, Rika ; Schindler, Michael</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c7635-d4cfe12fa201ef03a4a4147169fd77a158fb0a2d4781b88468ba4492420bf8323</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Acquired immune deficiency syndrome</topic><topic>Adult</topic><topic>Aged</topic><topic>AIDS</topic><topic>AIDS/HIV</topic><topic>Antiviral agents</topic><topic>Cells</topic><topic>Cloning</topic><topic>Control</topic><topic>Dosage and administration</topic><topic>Drug therapy</topic><topic>Experiments</topic><topic>Female</topic><topic>Health aspects</topic><topic>Hepatitis</topic><topic>HIV</topic><topic>HIV infections</topic><topic>HIV Infections - genetics</topic><topic>HIV Infections - immunology</topic><topic>HIV Infections - virology</topic><topic>HIV patients</topic><topic>HIV-1 - physiology</topic><topic>HIV‐1</topic><topic>Human immunodeficiency virus</topic><topic>Humans</topic><topic>Immune system</topic><topic>in vivo relevance</topic><topic>Infections</topic><topic>Interferon</topic><topic>Leukocytes, Mononuclear - immunology</topic><topic>Leukocytes, Mononuclear - virology</topic><topic>Lymphocytes</topic><topic>Male</topic><topic>Middle Aged</topic><topic>p21</topic><topic>Patients</topic><topic>Physiological aspects</topic><topic>Proteins</topic><topic>restriction factors</topic><topic>RISP</topic><topic>SAM Domain and HD Domain-Containing Protein 1 - genetics</topic><topic>SAM Domain and HD Domain-Containing Protein 1 - immunology</topic><topic>SAMHD1</topic><topic>SerinC5</topic><topic>T cells</topic><topic>T-Lymphocytes - immunology</topic><topic>T-Lymphocytes - virology</topic><topic>Tetherin</topic><topic>Viral Load</topic><topic>Viruses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bolduan, Sebastian</creatorcontrib><creatorcontrib>Koppensteiner, Herwig</creatorcontrib><creatorcontrib>Businger, Ramona</creatorcontrib><creatorcontrib>Rebensburg, Stephanie</creatorcontrib><creatorcontrib>Kunze, Christine</creatorcontrib><creatorcontrib>Brack‐Werner, Ruth</creatorcontrib><creatorcontrib>Draenert, Rika</creatorcontrib><creatorcontrib>Schindler, Michael</creatorcontrib><collection>Wiley Online Library (Open Access Collection)</collection><collection>Wiley Online Library (Open Access Collection)</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Access via ProQuest (Open Access)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of the International AIDS Society</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bolduan, Sebastian</au><au>Koppensteiner, Herwig</au><au>Businger, Ramona</au><au>Rebensburg, Stephanie</au><au>Kunze, Christine</au><au>Brack‐Werner, Ruth</au><au>Draenert, Rika</au><au>Schindler, Michael</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>T cells with low CD2 levels express reduced restriction factors and are preferentially infected in therapy naïve chronic HIV‐1 patients</atitle><jtitle>Journal of the International AIDS Society</jtitle><addtitle>J Int AIDS Soc</addtitle><date>2017</date><risdate>2017</risdate><volume>20</volume><issue>1</issue><spage>21865</spage><epage>n/a</epage><pages>21865-n/a</pages><issn>1758-2652</issn><eissn>1758-2652</eissn><abstract>Introduction: Restriction factors (RFs) suppress HIV‐1 in cell lines and primary cell models. Hence, RFs might be attractive targets for novel antiviral strategies, but their importance for virus control in vivo is controversial.
Methods: We profiled the expression of RFs in primary blood‐derived mononuclear cells (PBMC) from therapy‐naïve HIV‐1 patients and quantified infection.
Results: Overall, there was no correlation between individual RF expression and HIV‐1 status in total PBMC. However, we identified a T cell population with low levels of intracellular CD2 and reduced expression of SAMHD1, p21 and SerinC5. CD2low T cells with reduced RF expression were markedly positive for HIV‐1 p24. In contrast, CD2+ T cells were less infected and expressed higher levels of RFs. CD2low T cell infection correlated with viral loads and was associated with HIV‐1 disease progression.
Conclusions: In untreated therapy naïve chronic HIV‐1 patients, RF expression in T cells is associated with CD2 expression and seems to influence viral loads. Our study suggests that RFs help to control HIV‐1 infection in certain T cells in vivo and supports the potential for RFs as promising targets for therapeutic intervention.</abstract><cop>Switzerland</cop><pub>International AIDS Society</pub><pmid>28953327</pmid><doi>10.7448/IAS.20.1.21865</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1758-2652 |
ispartof | Journal of the International AIDS Society, 2017, Vol.20 (1), p.21865-n/a |
issn | 1758-2652 1758-2652 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5964667 |
source | MEDLINE; DOAJ Directory of Open Access Journals; Access via Wiley Online Library; EZB-FREE-00999 freely available EZB journals; Wiley Online Library (Open Access Collection); PubMed Central |
subjects | Acquired immune deficiency syndrome Adult Aged AIDS AIDS/HIV Antiviral agents Cells Cloning Control Dosage and administration Drug therapy Experiments Female Health aspects Hepatitis HIV HIV infections HIV Infections - genetics HIV Infections - immunology HIV Infections - virology HIV patients HIV-1 - physiology HIV‐1 Human immunodeficiency virus Humans Immune system in vivo relevance Infections Interferon Leukocytes, Mononuclear - immunology Leukocytes, Mononuclear - virology Lymphocytes Male Middle Aged p21 Patients Physiological aspects Proteins restriction factors RISP SAM Domain and HD Domain-Containing Protein 1 - genetics SAM Domain and HD Domain-Containing Protein 1 - immunology SAMHD1 SerinC5 T cells T-Lymphocytes - immunology T-Lymphocytes - virology Tetherin Viral Load Viruses |
title | T cells with low CD2 levels express reduced restriction factors and are preferentially infected in therapy naïve chronic HIV‐1 patients |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T22%3A29%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=T%20cells%20with%20low%20CD2%20levels%20express%20reduced%20restriction%20factors%20and%20are%20preferentially%20infected%20in%20therapy%20na%C3%AFve%20chronic%20HIV%E2%80%901%20patients&rft.jtitle=Journal%20of%20the%20International%20AIDS%20Society&rft.au=Bolduan,%20Sebastian&rft.date=2017&rft.volume=20&rft.issue=1&rft.spage=21865&rft.epage=n/a&rft.pages=21865-n/a&rft.issn=1758-2652&rft.eissn=1758-2652&rft_id=info:doi/10.7448/IAS.20.1.21865&rft_dat=%3Cgale_pubme%3EA518588519%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2290308790&rft_id=info:pmid/28953327&rft_galeid=A518588519&rfr_iscdi=true |